LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.500
-0.010 (-0.66%)
At close: Sep 17, 2025, 4:00 PM EDT
1.500
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:00 PM EDT
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $39.46 million as of September 17, 2025. Its market cap has decreased by -18.01% in one year.
Market Cap
39.46M
Enterprise Value
-16.45M
1-Year Change
-18.01%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $39.46M, a decrease of -89.62%. That is a compound annual growth rate of -39.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 39.72M | 58.82% |
| Dec 31, 2024 | 25.01M | -39.79% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
| Mar 25, 2021 | 380.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |